NCT00697346 2019-05-31Study of MLN8237 in Participants With Advanced Hematological MalignanciesTakedaPhase 1 Completed58 enrolled 52 charts
NCT01567709 2018-04-11Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell LymphomaNational Cancer Institute (NCI)Phase 1 Completed34 enrolled
NCT01466881 2016-03-10Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin LymphomaNational Cancer Institute (NCI)Phase 2 Completed42 enrolled 10 charts